Liquid biopsy: From discovery to clinical implementation
Klaus Pantel, Chairman of the Institute of Tumour Biology, University Centre Hamburg-Eppendorf
You may also like
Eric Green, Director, National Human Genome Research Institute (NHGRI)
Stephanie Devaney, Chief Operating Officer, All of Us Research Programme,National Institutes of Health (NIH)
Marshall Summar, Director, Rare Disease Institute, Children’s National Health System
Andrew Morris, Director, HDRUK
Mark Effingham, Deputy Chief Executive Officer, UK Biobank
Chris Wigley, Chief Executive Officer, Genomics England
Sir Patrick Vallance, Government Chief Scientific Adviser, UK Government
Dame Sue Hill, Chief Scientific Officer, NHS England and NHS Improvement
